Optimizing management of ruxolitinib in patients with myelofibrosis: the need for individualized dosing

Overview of attention for article published in Journal of Hematology & Oncology, October 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

So far, Dimensions has found 52 publications that cite this research output.

Article in Current Hematologic Malignancy Reports (March 2024)

Article in Journal of Hematology & Oncology (July 2023)

Article in Blood Advances (July 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.